Condition
Epigenetic Changes
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
Trial Status
Completed1
Terminated1
Unknown1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06372054Recruiting
TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models
NCT02557191Terminated
Biomarkers, Neurodevelopment and Preterm Infants
NCT03462797Completed
Opioid Physiology Project
NCT01255384Unknown
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
Showing all 4 trials